Literature DB >> 15613071

Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients.

Juan M López-Gómez1, Maite Villaverde, Rosa Jofre, Patrocinio Rodriguez-Benítez, Rafael Pérez-García.   

Abstract

BACKGROUND: Excessive interdialytic weight gain (IDWG) is usually related to an overload of sodium and water, and is the most important factor for arterial hypertension in dialysis. On the other hand, food intake also contributes to IDWG, and is the basic factor for nutrition. The objective of this study is to assess the long-term prognostic effect of IDWG and its relationship with the nutritional status and blood pressure in patients in hemodialysis (HD).
METHODS: We describe the results of a 5-year prospective observation study in which 134 HD patients were included (70 males and 64 females), with ages between 18 and 81. Initially, the average data were collected during 4 weeks, including total IDWG and percentages according to dry weight (IDWG%), nutritional parameters, and blood pressure. Patients were divided into 3 cohorts according to IDWG% (<2.9, 2.9-3.9, and >3.9%, respectively). Student t test, ANOVA, linear regression analysis, and Kaplan-Meier survival curves compared with log-rank test were used as statistical tools.
RESULTS: The mean IDWG% for the whole studied population was 3.5 +/- 1.1% (1.5-8.0%). It was not related to gender, but had an inverse correlation with age (P < 0.000) and serum bicarbonate level (P= 0.009). It was directly correlated with predialysis systolic and diastolic blood pressure, nPCR, urea and creatinine levels (P < 0.01 for all of them), and the body mass index (P < 0.000). Serum levels of albumin (44.7 +/- 4.0 g/dL) and prealbumin (31.9 +/- 7.4 mg/dL) had a direct correlation with total IDWG (P < 0.01). We found no significant relationship between or IDWG% and ferritin and transferrin levels. Five-year actuarial survival was 0.38, 0.52, and 0.63, respectively, in the 3 cohorts for IDWG% (P < 0.01).
CONCLUSION: Our results show that a greater IDWG is directly associated with a better nutritional status, although it is also associated with higher predialysis blood pressure. The greater the IDWG%, the better the long-term prognosis of the patients. The beneficial effects of IDWG on the nutritional status and prognosis are greater than the negative aspects that depend on its effects on blood pressure. One must distinguish clearly between some isolated instances of not complying with a diet from those situations where a higher IDWG is merely a reflection of a good nutritional status, and one must be careful so that dietary recommendations will not have a negative influence on nutritional aspects. One must watch and correct the trend towards higher acidosis in patients with a greater IDWG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613071     DOI: 10.1111/j.1523-1755.2005.09314.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  29 in total

1.  Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study.

Authors:  Rene' G VanDeVoorde; Gina M Barletta; Deepa H Chand; Ian G Dresner; Jerome Lane; Jeffrey Leiser; Jen-Jar Lin; Cynthia G Pan; Hiren Patel; Rudolph P Valentini; Mark M Mitsnefes
Journal:  Pediatr Nephrol       Date:  2006-11-07       Impact factor: 3.714

2.  Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients.

Authors:  J K Inrig; E Z Oddone; V Hasselblad; Barbara Gillespie; U D Patel; D Reddan; R Toto; J Himmelfarb; J F Winchester; J Stivelman; R M Lindsay; L A Szczech
Journal:  Kidney Int       Date:  2007-01-10       Impact factor: 10.612

Review 3.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

4.  Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis.

Authors:  Daniel Cukor; Nisha Ver Halen; Deborah Rosenthal Asher; Jeremy D Coplan; Jeremy Weedon; Katarzyna E Wyka; Subodh J Saggi; Paul L Kimmel
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

5.  A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.

Authors:  Steven Fishbane; Martin Ford; Masafumi Fukagawa; Kieran McCafferty; Anjay Rastogi; Bruce Spinowitz; Konstantin Staroselskiy; Konstantin Vishnevskiy; Vera Lisovskaja; Ayman Al-Shurbaji; Nicolas Guzman; Sunil Bhandari
Journal:  J Am Soc Nephrol       Date:  2019-06-14       Impact factor: 10.121

6.  Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.

Authors:  Jennifer E Flythe; Abhijit V Kshirsagar; Ronald J Falk; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

7.  Role of clinical pharmacist in the management of blood pressure in dialysis patients.

Authors:  Bonyan Qudah; Abla Albsoul-Younes; Ezat Alawa; Nabil Mehyar
Journal:  Int J Clin Pharm       Date:  2016-05-18

8.  Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients.

Authors:  Jula K Inrig; Uptal D Patel; Barbara S Gillespie; Vic Hasselblad; Jonathan Himmelfarb; Donal Reddan; Robert M Lindsay; James F Winchester; John Stivelman; Robert Toto; Lynda A Szczech
Journal:  Am J Kidney Dis       Date:  2007-07       Impact factor: 8.860

9.  The mortality risk of overhydration in haemodialysis patients.

Authors:  Volker Wizemann; Peter Wabel; Paul Chamney; Wojciech Zaluska; Ulrich Moissl; Christiane Rode; Teresa Malecka-Masalska; Daniele Marcelli
Journal:  Nephrol Dial Transplant       Date:  2009-01-07       Impact factor: 5.992

10.  A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient.

Authors:  Mary Ann Sevick; Roslyn A Stone; Matthew Novak; Beth Piraino; Linda Snetselaar; Rita M Marsh; Beth Hall; Heather Lash; Judith Bernardini; Lora E Burke
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.